PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Internal Medicine, Hematology and Oncology, Faculty of Medicine, University Hospital Brno and Masaryk University, Jihlavska 20, Brno, 625 00, Czech Republic. krejci.marta@fnbrno.cz.\', \'Department of Internal Medicine, Hematology and Oncology, Faculty of Medicine, University Hospital Brno and Masaryk University, Jihlavska 20, Brno, 625 00, Czech Republic.\', \'Babak Myeloma Group, Department of Pathophysiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1007/s00277-021-04594-w
?:hasPublicationType
?:journal
  • Annals of hematology
is ?:pmid of
?:pmid
?:pmid
  • 34309714
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.043
?:rankingScore_hIndex
  • 70
is ?:relation_isRelatedTo_publication of
?:title
  • Outcome of COVID-19 infection in 50 multiple myeloma patients treated with novel drugs: single-center experience.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34309714>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34309714>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all